HomeCompareEW vs SAIA

EW vs SAIA: Dividend Comparison 2026

EW yields 2.52% · SAIA yields 0.60%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EW wins by $2.9K in total portfolio value
10 years
EW
EW
● Live price
2.52%
Share price
$79.50
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.4K
Annual income
$295.93
Full EW calculator →
SAIA
SAIA
● Live price
0.60%
Share price
$336.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.5K
Annual income
$61.87
Full SAIA calculator →

Portfolio growth — EW vs SAIA

📍 EW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEWSAIA
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EW + SAIA cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EW pays
SAIA pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EW
Annual income on $10K today (after 15% tax)
$213.84/yr
After 10yr DRIP, annual income (after tax)
$251.54/yr
SAIA
Annual income on $10K today (after 15% tax)
$50.59/yr
After 10yr DRIP, annual income (after tax)
$52.59/yr
At 15% tax rate, EW beats the other by $198.95/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EW + SAIA for your $10,000?

EW: 50%SAIA: 50%
100% SAIA50/50100% EW
Portfolio after 10yr
$22.0K
Annual income
$178.90/yr
Blended yield
0.81%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EW right now

EW
Analyst Ratings
32
Buy
16
Hold
Consensus: Buy
Price Target
$96.38
+21.2% upside vs current
Range: $87.00 — $110.00
Altman Z
10.9
Piotroski
5/9
SAIA
Analyst Ratings
17
Buy
14
Hold
1
Sell
Consensus: Buy
Price Target
$398.91
+18.7% upside vs current
Range: $262.00 — $493.00
Altman Z
8.2
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EW buys
0
SAIA buys
0
No recent congressional trades found for EW or SAIA in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEWSAIA
Forward yield2.52%0.60%
Annual dividend / share$2.00$2.00
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$23.4K$20.5K
Annual income after 10y$295.93$61.87
Total dividends collected$2.8K$608.00
Payment frequencyquarterlyquarterly
SectorHealthcareIndustrials
Analyst consensusBuyBuy
Analyst price target$96.38$398.91

Year-by-year: EW vs SAIA ($10,000, DRIP)

YearEW PortfolioEW Income/yrSAIA PortfolioSAIA Income/yrGap
1← crossover$10,952$251.57$10,760$59.52+$192.00EW
2$11,976$257.49$11,573$59.85+$403.00EW
3$13,077$263.14$12,443$60.16+$634.00EW
4$14,261$268.55$13,374$60.46+$887.00EW
5$15,533$273.70$14,371$60.73+$1.2KEW
6$16,899$278.61$15,438$60.99+$1.5KEW
7$18,365$283.28$16,580$61.23+$1.8KEW
8$19,938$287.72$17,802$61.46+$2.1KEW
9$21,626$291.93$19,110$61.67+$2.5KEW
10$23,436$295.93$20,509$61.87+$2.9KEW

EW vs SAIA: Complete Analysis 2026

EWHealthcare

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Full EW Calculator →

SAIAIndustrials

Saia, Inc., through its subsidiaries, operates as a transportation company in North America. The company provides less-than-truckload services for shipments between 400 and 10,000 pounds; and other value-added services, including non-asset truckload, expedited, and logistics services. As of December 31, 2021, it operated 176 owned and leased facilities; and owned approximately 5,600 tractors and 19,300 trailers. The company was formerly known as SCS Transportation, Inc. and changed its name to Saia, Inc. in July 2006. Saia, Inc. was founded in 1924 and is headquartered in Johns Creek, Georgia.

Full SAIA Calculator →
📬

Get this EW vs SAIA comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EW vs SCHDEW vs JEPIEW vs OEW vs KOEW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.